Published in BMC Public Health on September 08, 2014
The lifestyle habits and wellbeing of physicians in Bahrain: a cross-sectional study. BMC Public Health (2015) 0.77
Waterpipe Tobacco Smoking Among Dental Practitioners: Prevalence and Health Perceptions. Tob Use Insights (2016) 0.75
Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax (2000) 9.36
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA (2014) 6.42
Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemic. Tob Control (2004) 5.97
Physician advice for smoking cessation. Cochrane Database Syst Rev (2013) 3.51
The global epidemic of waterpipe smoking. Addict Behav (2010) 3.13
Physician advice for smoking cessation. Cochrane Database Syst Rev (2004) 2.84
District programme to reduce smoking: effect of clinic supported brief intervention by general practitioners. Br Med J (Clin Res Ed) (1987) 2.29
An old custom, a new threat to tobacco control. Am J Public Health (2006) 2.18
State-specific secondhand smoke exposure and current cigarette smoking among adults - United States, 2008. MMWR Morb Mortal Wkly Rep (2009) 2.11
Gender and smoking status-based analysis of views regarding waterpipe and cigarette smoking in Aleppo, Syria. Prev Med (2004) 1.71
Health practices of Canadian physicians. Can Fam Physician (2009) 1.56
A comparison of cigarette- and hookah-related videos on YouTube. Tob Control (2012) 1.53
Knowledge of and attitudes towards tobacco control among smoking and non-smoking physicians in 2 Gulf Arab states. Saudi Med J (2004) 1.19
Attitudes and behaviours in smoking cessation among general practitioners in Finland 2001. Soz Praventivmed (2005) 1.17
Smoking habits and attitudes towards smoking among Estonian physicians. Public Health (2005) 1.08
Use of tobacco and alcohol by Swiss primary care physicians: a cross-sectional survey. BMC Public Health (2007) 1.06
Beliefs and perceptions toward quitting waterpipe smoking among cafe waterpipe tobacco smokers in Bahrain. Nicotine Tob Res (2013) 0.95
Smoking habits of primary health care physicians in Bahrain. J R Soc Promot Health (1999) 0.92
Tobacco education in medical schools: survey among primary care physicians in Bahrain. East Mediterr Health J (2010) 0.92
Study of the smoking behavior of medical doctors in Fukui, Japan and their antismoking measures. J Epidemiol (2000) 0.82
Beliefs and perceptions toward quitting waterpipe smoking among cafe waterpipe tobacco smokers in Bahrain. Nicotine Tob Res (2013) 0.95
Relevance of serum levels of interleukin-6 and syndecan-1 in patients with hepatocellular carcinoma. Sci Pharm (2011) 0.85
Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients. Hematology (2013) 0.83
Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway. J Pharm Pharmacol (2014) 0.82
Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers. Clin Exp Metastasis (2015) 0.78
Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy. Ann Hematol (2014) 0.77
64 multidetector CT findings of influenza A (H1N1) virus in patients with hematologic malignancies. Acta Radiol (2012) 0.77
Validity of osteoprotegerin and receptor activator of NF-κB ligand for detection of bone metastasis in breast cancer. Oncol Res (2016) 0.75
Cytotoxic effects of suramin against HepG2 cells through activation of intrinsic apoptotic pathway. J BUON (2014) 0.75
Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma. Sci Pharm (2013) 0.75
Phase II study of capecitabine plus cisplatin in patients with gastric cancer. Anticancer Drugs (2009) 0.75
The Pervasive Culture of Abuse in Medical Education: A Focus on Developing Countries. Acad Med (2017) 0.75
Prognostic significance of FLT3 internal tandem duplication in egyptian patients with acute myeloid leukemia with normal or favorable risk cytogenetics. Egypt J Immunol (2010) 0.75